Search research articles
Contact Us
Filters
Showing results (131-140 of 161) with videos related to
Page
of 17
Sort By:
Journal of Gastroenterology and Hepatology
|
August 12, 2016
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients
Kei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
The Journal of Infection
|
December 26, 2021
Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibody
Haruna Hatooka, Yumi Shimomura, Michio Imamura, et al.
Antiviral Therapy
|
September 22, 2017
The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients
Mio Kurihara, Masataka Tsuge, Eisuke Murakami, et al.
Journal of Gastroenterology and Hepatology
|
July 21, 2023
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure
Serami Murakami, Takuro Uchida, Michio Imamura, et al.
Gut
|
January 17, 2013
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
Niu Shi, Nobuhiko Hiraga, Michio Imamura, et al.
Journal of Viral Hepatitis
|
June 9, 2021
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Yuno Nishida, Michio Imamura, Yuji Teraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 7, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma
Ryoichi Miura, Tomokazu Kawaoka, Saki Sueda, et al.
Biochemical and Biophysical Research Communications
|
May 1, 2021
Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice
Kazuki Ohya, Michio Imamura, Yuji Teraoka, et al.
The Journal of General Virology
|
June 15, 2019
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice
Mitsutaka Osawa, Takuro Uchida, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 3, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C
Yuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 161) with videos related to
Sort By:
Page
of 17
Journal of Gastroenterology and Hepatology
|
August 12, 2016
Real-world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus-infected cirrhosis patients
Kei Morio, Michio Imamura, Yoshiiku Kawakami, et al.
The Journal of Infection
|
December 26, 2021
Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibody
Haruna Hatooka, Yumi Shimomura, Michio Imamura, et al.
Antiviral Therapy
|
September 22, 2017
The association between serum cytokine and chemokine levels and antiviral response by entecavir treatment in chronic hepatitis B patients
Mio Kurihara, Masataka Tsuge, Eisuke Murakami, et al.
Journal of Gastroenterology and Hepatology
|
July 21, 2023
Correlation between serum pro-inflammatory cytokine levels and the prognosis of the patients with acute liver failure
Serami Murakami, Takuro Uchida, Michio Imamura, et al.
Gut
|
January 17, 2013
Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice
Niu Shi, Nobuhiko Hiraga, Michio Imamura, et al.
Journal of Viral Hepatitis
|
June 9, 2021
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients
Yuno Nishida, Michio Imamura, Yuji Teraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 7, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular Carcinoma
Ryoichi Miura, Tomokazu Kawaoka, Saki Sueda, et al.
Biochemical and Biophysical Research Communications
|
May 1, 2021
Novel drug resistance-associated substitutions against pibrentasvir emerged in genotype 1b hepatitis C virus-infected human hepatocyte transplanted mice
Kazuki Ohya, Michio Imamura, Yuji Teraoka, et al.
The Journal of General Virology
|
June 15, 2019
Efficacy of glecaprevir and pibrentasvir treatment for genotype 1b hepatitis C virus drug resistance-associated variants in humanized mice
Mitsutaka Osawa, Takuro Uchida, Michio Imamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
April 3, 2014
Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C
Yuko Nagaoki, Michio Imamura, Yoshiiku Kawakami, et al.
Page
of 17